Data as of Dec 06
| -0.17 / -1.59%|
The 1 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 15.00. The median estimate represents a +42.31% increase from the last price of 10.54.
The current consensus among 1 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.